A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular Response.

A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular Response. Clin Cancer Res. 2021 05 15; 27(10):2734-2741.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Hormonal
Antineoplastic Combined Chemotherapy Protocols
Benzamides
Clinical Decision-Making
Disease Management
Endometrial Neoplasms
Female
Humans
Hysterectomy
Medroxyprogesterone Acetate
Middle Aged
Pyridines
Time-to-Treatment
Treatment Outcome

authors with profiles

Joan L Walker
Laura L Holman